Trials / Completed
CompletedNCT03906175
Whole-body Hyperthermia for Mild to Moderate Depressive Disorder
Whole-body Hyperthermia for Mild to Moderate Depressive Disorder - a Randomized Controlled Tiral
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Universität Duisburg-Essen · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this study is to investigate the effectiveness of whole-body hyperthermia in comparison to wait list on depressive symptom severity in patients with mild to moderate depressive disorder currently not under psychotherapeutic or antidepressant drug treatment. Secondary aims included further quality of life outcomes, immunological parameters, and tolerability/safety of the hyperthermia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Whole-body hyperthermia | Whole-body hyperthermia will be applied two times during 4 weeks (week 0 and 2 after randomization). The hyperthermia will be applied using Heckel-HT3000 MPIIb. |
Timeline
- Start date
- 2019-06-11
- Primary completion
- 2023-08-31
- Completion
- 2023-09-01
- First posted
- 2019-04-08
- Last updated
- 2023-12-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03906175. Inclusion in this directory is not an endorsement.